Anticoagulants
The best tips and advice from our vast library of articles, videos, and business tools
Browse Related Topics
Free Industry Resources
Newly Added Articles
- SANBUSCO MARKET CENTER
- SPECIAL SESSION 30-day limit in haven cases heads...
- Time off the air takes toll on Dahl
- The outdoors is his calling: French will be...
- BANKRUPT MIAMI BROKER PLANS A COMEBACK FLAMBOYANT...
- Concerts have big year despite bad economy
- Internet expanding doctor-patient dialogue
Search Results
1-20 of 174 related articles
According to recent research from Singapore, Singapore, "Recent reports of catheter thrombosis among patients undergoing percutaneous coronary intervention...
unaggregatedarticle
Washington Editor ImaRx Therapeutics Inc., which is working on anti-clotting therapies, filed for an estimated $75 million initial...
unaggregatedarticle
PHILADELPHIA - Warfarin, one of the most inconvenient, dangerous and disliked drugs in the world, has remained vitally...
unaggregatedarticle
Dabigatran vs warfarin: Less bleeding? Source: Connolly SJ, et al. Dabigatran versus warfarin in patientswith atrial fibrillation. N...
unaggregatedarticle
"Summaries of product characteristics (SPCs) and clinical guideline recommendations are available for monitoring the platelet count forheparin-induced thrombocytopenia...
unaggregatedarticle
Oct. 20--Warfarin, one of the most inconvenient, dangerous, and disliked drugs in the world, has remained vitally important...
unaggregatedarticle
Warfarin, one of the most inconvenient, dangerous, and disliked drugs in the world, has remained vitally important for...
unaggregatedarticle
PHILADELPHIA _ Warfarin, one of the most inconvenient, dangerous and disliked drugs in the world, has remained vitally...
unaggregatedarticle
"Atrial fibrillation and atrial flutter are common cardiac arrhythmias associated with an increased risk of stroke in patients...
unaggregatedarticle
In this recently published article, scientists in Liverpool, the United Kingdom conducted a study "To report a case...
unaggregatedarticle
According to a study from the United States, "Currently, the only FDA-approved therapy for acute ischemic stroke is...
unaggregatedarticle
Staff Writer Emisphere Technologies Inc. said Tuesday that its Phase III trial of oral heparin failed to show...
unaggregatedarticle
Research findings, 'Barriers to the optimal use of anticoagulants after orthopaedic surgery,' are discussed in a new report....
unaggregatedarticle
"Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical...
unaggregatedarticle
"Several studies have attempted to identify predictors of outcome following ischaemic stroke. Reduced stroke severity has been reportedwith...
unaggregatedarticle
Science Editor It improves outcomes for patients, but for Genentech Inc. 's Activase itself, the outcome has not...
unaggregatedarticle
West Coast Editor With the way apparently clearing for approval of its low-molecular-weight heparin, Momenta Pharmaceuticals Inc. raised...
unaggregatedarticle
Staff Writer Thrombolytic drug developer Imarx Therapeutics Inc. priced its initial public offering lower than expected, selling 3...
unaggregatedarticle
Staff Writer Redirecting its resources toward core anti-inflammatory programs, Inflazyme Pharmaceuticals Inc. dropped development of an antithrombotic agent...
unaggregatedarticle
"SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis....
unaggregatedarticle
Are You Ready to Start Your Dream Business?
Sumer Morenz of D&B Digital TV hits the streets of San Francisco to ask people about the businesses they want to start.
Franchise Finder
Find your perfect franchise
Choose your location and industry and we'll show you the most relevant franchises.
Sponsored Links
Site Map | Contact Us | FAQs | About Us | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Media Kit
Copyright © 1999 - 2009 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report?
Online Business Database | Online Business Information | Sales and Marketing Solutions | Business Mailing Lists | Company Profiles
Online Business Database | Online Business Information | Sales and Marketing Solutions | Business Mailing Lists | Company Profiles
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
